检索结果 - Jenny F. Seligmann

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer

    The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer 由 Julien Taı̈eb, Andreas Jung, Andrea Sartore‐Bianchi, Marc Peeters, Jenny F. Seligmann, Aziz Zaanan, Peter Burdon, Clara Montagut, Pierre Laurent‐Puig

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With<i>RAS</i>Wild-Type Advanced Colorectal Cancer

    Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With<i>RAS</i>Wild-Type Advanced Col... 由 Jenny F. Seligmann, Faye Elliott, Susan D. Richman, Bart Jacobs, Gemma Hemmings, Sarah Brown, Jennifer H. Barrett, Sabine Tejpar, Philip Quirke, Michel Seymour

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up 由 Andrés Cervantes, R. Adam, Susana Roselló, Dirk Arnold, Nicola Normanno, Julien Taı̈eb, Jenny F. Seligmann, Thierry de Baère, Pia Österlund, Takayuki Yoshino, Erika Martinelli

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

    Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial 由 Dion Morton, Michel Seymour, Laura Magill, Kelly Handley, James Glasbey, Bengt Glimelius, Andy Palmer, Jenny F. Seligmann, Søren Laurberg, Keigo Murakami, Nicholas P. West, Philip Quirke, Richard Gray

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

    Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials 由 Jenny F. Seligmann, David J. Fisher, Christopher G. Smith, Susan D. Richman, Faye Elliott, Sarah Brown, Richard Adams, Tim Maughan, Philip Quirke, Jeremy P. Cheadle, Michel Seymour, Gary Middleton

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS , and NRAS (FOCUS4-D): a phase 2–3 randomised trial

    Inhibition of EGFR, HER2, and HER3 signalling in patients with colorectal cancer wild-type for BRAF, PIK3CA, KRAS , and NRAS (FOCUS4-D): a phase 2–3 randomised trial 由 Richard Adams, Ewan Brown, Louise Brown, Rachel Butler, Stephen Falk, David J. Fisher, Richard Kaplan, Philip Quirke, Susan D. Richman, Leslie Samuel, Jenny F. Seligmann, Michel Seymour, Kai Keen Shiu, Harpreet Wasan, Richard H. Wilson, Tim Maughan

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Inhibition of WEE1 Is Effective in<i>TP53</i>- and<i>RAS</i>-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring

    Inhibition of WEE1 Is Effective in<i>TP53</i>- and<i>RAS</i>-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitori... 由 Jenny F. Seligmann, David J. Fisher, Louise Brown, Richard Adams, Janet Graham, Philip Quirke, Susan D. Richman, Rachel Butler, Enric Domingo, Andrew Blake, Emma Yates, Michael Braun, Fiona Collinson, Robert H. Jones, Ewan Brown, Emma De Winton, Timothy C. Humphrey, Mahesh Parmar, Richard Kaplan, Richard H. Wilson, Michel Seymour, Tim Maughan

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial

    Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Tr... 由 Christopher J.M. Williams, Richard Gray, Robert K. Hills, Michael Shires, Liping Zhang, Zuo Zhao, Tracie Gardner, Nancy Sapanara, Xiaomeng Xu, Isaac Bai, Dongyao Yan, Andrea Murányi, Sarah Dance, Faranak Aghaei, Gemma Hemmings, Michael Hale, Uday Kurkure, Christoph Guetter, Susan D. Richman, Gordon Hutchins, Jenny F. Seligmann, Nicholas P. West, Shalini Singh, Kandavel Shanmugam, Philip Quirke

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: